TMRW Life Sciences, Inc. — SEC Form D Filing
TMRW Life Sciences, Inc. filed an SEC Form D on April 24, 2026, reporting $38.36M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- April 24, 2026
- Amount reported
- $38.36M
- Round stage
- Seed
- Industry
- Health Care
- Website
- https://www.tmrwlifesciences.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
With the increasing demand for fertility treatments, clinics require new solutions to optimize and safely scale the management and storage of frozen eggs and embryos.
Solution
TMRW provides an FDA-cleared automated platform for managing frozen eggs and embryos, featuring RFID tracking, a digital database, 24/7 monitoring, and safe transport solutions to ensure reliability and safety.
Why now
The increasing number of people using assisted reproductive technology has created a demand for reliable and efficient storage solutions for frozen eggs and embryos.
Verdict
Investors leaned in at this point because TMRW's solution addressed an urgent need for efficient fertility management, capitalizing on the burgeoning assisted reproductive technology market. They were betting on the premise that clinics would prioritize automation and safety enhancements in an increasingly competitive landscape. This cleared because the urgency of scalable solutions resonated strongly, not because existing manual processes were inherently faltering.
Source: SEC EDGAR Form D filing